MarketBeat's profile
Blog
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026
Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar performance. After tanking 14% on Aug. 7 due to poor clinical trial
3 Stocks at 52-Week Lows With Way More Upside Than Downside
Buying low and selling high is a tried-and-true strategy for both buy-and-hold investors and active traders. When a stock is trading at or near its 52-week low, the stock price is trading at one
4 Reasons Colgate-Palmolive Is a No-Brainer Hold Through 2027
Colgate-Palmolive (NYSE: CL) is a buy-and-hold quality stock offering significant incentives to consumer staples investors. The stock is trading at historically low valuations, pays a
Amid Tech Volatility, These 3 Stocks Are Up & Boosting Buybacks
Since the end of October, technology stocks have seen significant volatility. The Technology Select Sector SPDR Fund (NYSEARCA: XLK) reached a split-adjusted all-time high of around $152 on Oct
Sector Rotation: 2 Smart Money Moves for 2026
The Federal Reserve has officially shifted gears. By lowering interest rates in mid-December 2025, the Fed sent a decisive signal to the global markets. For the better part of the last year, the

